Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-29

Clinical Trial Update: The Effect of Lidocaine - Prilocaine Cream (EMLA) Versus Mepivacaine Infiltration on Pain Relief During And After Mediolateral Episiotomies [Phase 4]

View source ↗

Summary

Phase 4 trial comparing lidocaine/prilocaine cream (EMLA) to mepivacaine infiltration for pain relief during and after mediolateral episiotomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EMLA Cream (lidocaine 2.5% / prilocaine 2.5% topical cream)
  • Mepivacaine (mepivacaine)

Snippet

Sponsor: Cairo University | Conditions: Episiotomy Pain | Phase 4 | Status: UNKNOWN